Development of agonists of endothelin-1 exhibiting selectivity towards ETA receptors

British Journal of Pharmacology

Volumn 139, Issue 3, 2003, Pages 616-622

  Langlois, Chantal ^a   Létourneau, Myriam ^a   Lampron, Philipe ^a   St Hilaire, Véronique ^a   Fournier, Alain ^a,b  

^a INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

^b Lab Etud Moleculaires/P   (Canada)

Author keywords

Bioassays; Endothelin; Intramolecular ionic bond; Structure activity relation

Indexed keywords

CYCLOENDOTHELIN 1 [9-21][11-15][9 DEXTRO LYSINE]; ENDOTHELIN 1; ENDOTHELIN 1 DERIVATIVE; ENDOTHELIN 1 [11-21]; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMICAL BOND; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; GUINEA PIG; INTRAMOLECULAR IONIC BOND; LUNG PARENCHYMA; NONHUMAN; PEPTIDE SYNTHESIS; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; THORACIC AORTA; VASOCONSTRICTION;

EID: 0037664280     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705252     Document Type: Article

References (47)

1. ANDERSEN, N.H., CHEN, C.P., MARSCHNER, T.M., KRYSTEK Jr, S.R. & BASSOLINO, D.A. (1992). Conformational isomerism of endothelin in acidic aqueous media: a quantitative NOESY analysis. Biochemistry, 31, 1280 - 1295.
2. ASTLES, P.C., BREALY, C., BROWN, T.J., HALLEY, F., FAACCHINI, V., HANDSCOMBE, C.M., HARRIS, N.V., MCCARTY, C., MCLAY, I.M., PORTER, B., RAOCH, A.G., SARGENT, C., SMITH, C. & WALSH, R.J.A. (1998a) Selective endothelin A receptor antagonists. 3. Discovery and structure - activity relationships of a series of 4-phenoxybutanoic acid derivatives. J. Med. Chem., 41, 2732 - 2744.
3. ASTLES, P.C., BROWN, T.J., HALLEY, F., HANDSCOMBE, C.M., HARRIS, N.V., MCCARTY, C., MCLAY, I.M., LOCKEY, P., MAJID, T., PORTER, B., RAOCH, A.G., SMITH, C. &WALSH, R. (1998b) Selective endothelin A receptor antagonists. 4. Discovery and structure - activity relationship of stilbene acid and alcohol derivatives. J Med. Chem., 41, 2745 - 2753.
4. 7]-endothelin by 1H NMR. Int. J. Pept. Protein Res. 37, 315 - 324.
5. BOSS, C., BOLLI, M. & WELLER, T. (2002). Endothelin receptor antagonists: structures, synthesis, selectivity and therapeutic applications. Curr. Med. Chem., 9, 349 - 383.
6. BOULANGER, C.M. (1999). Secondary endothelial dysfunction: hypertension and heart failure. J. Mol. Cell Cardiol., 31, 39 - 49.
7. BOULANGER, Y., BIRON, E., KHIAT, A. & FOURNIER, A. (1999). Conformational analysis of biologically active truncated linear analogs of endothelin-1 using NMR and molecular modeling. J. Pept. Res., 53, 214 - 222.
8. DASGUPTA, F., MUKHERJEE, A.K. & GANGADHAR, N. (2002) Endothelin receptor antagonists - an overview. Curr. Med. Chem., 9, 549 - 575.
9. DAVENPORT, A.P., O'REILLY, G., MOLENAAR, P., MAGUIRE, J.J., KUC, R.E., SHARKEY, A., BACON, C.R. & FERRO, A. (1993). Human endothelin receptors characterized using reverse transcriptase - polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J. Cardiovasc. Pharmacol., 22(Suppl 8), S22 - S25.
10. DE ARTIÑANO, A.A. & GONZALEZ, V.L. (1999). Endothelial dysfunction and hypertensive vasoconstriction. Pharmacol. Res., 40, 113 - 124.
11. DOHERTY, A.M., CODY, W.L., LEITZ, N.L., DEPUE, P.L., TAYLOR, M.D., RAPUNDALO, S.T., HINGORANI, G.P., MAJOR, T.C., PANEK, R.L. & TAYLOR, D.G. (1991). Structure - activity studies of the C-terminal region of the endothelins and the sarafotoxins. J. Cardiovasc. Pharmacol., 17(Suppl 7), S59 - S61.
12. DOHERTY, A.M. & PATT, W.C. (1997). Development of endothelin antagonists. In: Endothelins in Biology and Medicine. eds. Huggins, J.P. & Pelton, J.T., pp. 327 - 346. CRC Press Inc., New York.
13. ENDO, S., INOOKA, H., ISHIBASHI, Y., KITADA, C., MIZUTA, E. & FUJINO, M. (1989). Solution conformation of endothelin determined by nuclear magnetic resonance and distance geometry. FEBS Lett., 257, 149 - 154.
14. FOREST, M., MARTEL, J.C., ST-PIERRE, S., QUIRION, R. & FOURNIER, A. (1990). Structural study of the N-terminal segment of neuropeptide-tyrosine. J. Med. Chem., 33, 1615 - 1619.
15. FORGET, M-A., LEBEL, N., SIROIS, P., BOULANGER, Y. & FOURNIER, A. (1996) Biological and molecular analyses of structurally reduced analogs of endothelin-1. Mol. Pharmacol., 49, 1071 - 1079.
16. GALANTINO, M., DE CASTIGLIONE, R., CRISTIANI, C., VAGHI, F., LIU, W., ZHANG, J.W. & TAM, J.P. (1995). D-Amino acid scan of endothelin: importance of amino acids adjacent to cysteinyl residues in isomeric selectivity. Pept. Res., 8, 154 - 159.
17. HEITZ, A., LE-NGUYEN, D. & CHICHE, L. (1999). Min-21 and min-23, the smallest peptides that fold like a cystine-stabilized beta-sheet motif: design, solution structure, and thermal stability. Biochemistry, 38, 10615 - 10625.
18. HEMPEL, J.C., FINE, R.M., GUARAGNA, A., HASSAN, M., KOERBER, S.C. & HAGLER, A.T. (1994). Effects of solvatation on the conformational preferences of ET-1. In: Peptides: Chemistry, Structure and Biology. eds. Hodges, R.S. & Smith, J.A., pp. 890 - 891. ESCOM Science Publishers B.V., Leiden, The Netherlands.
19. HEWAGE, C.M., JIANG, L., PARKINSON, J.A., RAMAGE, R. & SADLER, I.H. (1999). A linear endothelin-1 analogue: solution structure of ET-1[Aib1,3,11,15, Nle7] by nuclear magnetic resonance spectroscopy and molecular modelling. Neurochem. Int., 35, 35 - 45.
20. HEWAGE, C.M., JIANG, L., PARKINSON, J.A., RAMAGE, R. & SADLER, I.H. (2002). Design of ET(B) receptor agonists: NMR spectroscopic and conformational studies of ET7-21[Leu7, Aib11, Cys(Acm)15]. Protein. Eng., 15, 161 - 167.
21. HUGGINS, J.P., PELTON, J.T. & MILLER, R.C. (1993). The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol. Ther., 59, 55 - 123.
22. JANES, R.W., PEAPUS, D.H. & WALLACE, B.A. (1994). The crystal structure of human endothelin. Nat. Struct. Biol., 1, 311 - 319.
23. JONES, C.R., HILEY, C.R., PELTON, J.T. & MILLER, R.C. (1991) Endothelin receptor heterogeneity; structure activity, autoradiographic and functional studies. J. Recept. Res., 11, 299 - 310.
24. KATAHIRA, R., UMEMURA, I., TAKAI, M., ODA, K., OKADA, T. & NOSAKA, A.Y. (1998). Structural studies on endothelin receptor subtype B specific agonist IRL 1620. J. Pept. Res., 51, 155 - 164.
25. KIMURA, S., KASUYA, Y., SAWAMURA, T., SHINMI, O., SUGITA, Y., YANAGISAWA, M., GOTO, K. & MASAKI, T. (1988). Structure - activity relationships of endothelin: importance of the C-terminal moiety. Biochem. Biophys. Res. Commun., 156, 1182 - 1186.
26. NAKAJIMA, K., KUBO, S., KUMAGAYE, S., NISHIO, H., TSUNEMI, M., INUI, T., KURODA, H., CHINO, N., WATANABE, T.X. & KIMURA, T. (1989). Structure - activity relationship of endothelin: importance of charged groups. Biochem. Biophys. Res. Commun., 163, 424 - 429.
27. NGUYEN, P.V., YANG, X.-P., LI, G., DENG, L.Y., FLÜCKIGER, J.-P. & SCHIFFRIN, E.L. (1993). Contractile responses and signal transduction of endothelin-1 in aorta and mesenteric vasculature of adult spontaneously hypertensive rats. Can. J. Physiol. Pharmacol. 71, 473 - 483.
28. OPGENORTH, T.J. (1995). Endothelin receptor antagonism. Adv. Pharmacol., 33, 1 - 65.
29. ORRY, A.J. & WALLACE, B.A. (2000). Modeling and docking the endothelin G-protein-coupled receptor. Biophys. J., 79, 3083 - 3094.
30. ORTEGA MATEO, A. & DE ARTIÑANO, A.A. (1997). Highlights on endothelins: a review. Pharmacol. Res., 36, 339 - 351.
31. PELTON, J.T. (1997). Endothelin agonists. In: Endothelins in Biology and Medicine. eds. Huggins, J.P. & Pelton, J.T. pp. 307 - 325. CRC Press Inc., New York.
32. PELTON, J.T. & MILLER, R.C. (1991). The role of the disulfide bonds in endothelin-1. J. Pharm. Pharmacol., 43, 43 - 45.
33. PERKINS, T.D., HIDER, R.C. & BARLOW, D.J. (1990). Proposed solution structure of endothelin. Int. J. Pept. Protein Res., 36, 128 - 133.
34. ROVERO, P., GALOPPINI, C., LARICCHIA-ROBBIO, L., MAZZONI, M.R. & REVOLTELLA, R.P. (1998). Structure - activity analysis of C-terminal endothelin analogues. J. Cardiovasc. Pharmacol., 31(Suppl 1), S251 - S254.
35. ROVERO, P., PATACCHINI, R. & MAGGI, C.A. (1990). Structure - activity studies on endothelin (16 - 21), the C-terminal hexapeptide of the endothelins, in the guinea-pig bronchus. Br. J. Pharmacol., 101, 232 - 234.
36. SAEKI, T., IHARA, M., FUKURODA, T. & YANO, M. (1992) Structure - activity relationship for ETB agonism in truncated endothelin-1 analogs. Biochem. Int., 28, 305 - 312.
37. SAUDEK, V., HOFLACK, J. & PELTON, J.T. (1989). 1H-NMR study of endothelin, sequence-specific assignment of the spectrum and a solution structure. FEBS Lett., 257, 145 - 148.
38. SAUDEK, V., HOFLACK, J. & PELTON, J.T. (1991). Solution conformation of endothelin-1 by 1H NMR, CD, and molecular modeling. Int. J. Pept. Protein Res., 37, 174 - 179.
39. SPINELLA, M.J., MALIK, A.B., EVERITT, J. & ANDERSEN, T.T. (1991). Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction. Biochemistry, 88, 7443 - 7446.
40. TAM, J.P., LIU, W., ZHANG, J.W., GALANTINO, M., BERTOLERO, F., CRISTIANI, C., VAGHI, F. & DE CASTIGLIONE, R. (1994). Alanine scan of endothelin: importance of aromatic residues. Peptides, 15, 703 - 708.
41. TAYLOR, J.W. (2002). The synthesis and study of side-chain lactam-bridged peptides. Biopolymers, 66, 49 - 75.
42. VAN DER WALLE, C.F. & BARLOW, D.J. (1998). Investigations of structural requirements for endothelin antagonism. Curr. Med. Chem., 5, 321 - 335.
43. VANHOUTTE, P.M. (1996). Endothelial dysfunction in hypertension. J. Hyperten., 14(Suppl.), S83 - S93.
44. WALLACE, B.A. & JANES, R.W. (1995). The crystal structure of human endothelin-1 and how it relates to receptor binding. J. Cardiovasc. Pharmacol., 26(Suppl 3), S250 - S253.
45. WATANABE, T.X., ITAHARA, Y., NAKAJIMA, K., KUMAGAYE, S., KIMURA, T. & SAKAKIBARA, S. (1991). The biological activity of endothelin-1 analogues in three different assay systems. J. Cardiovasc. Pharmacol., 17(Suppl 7), S5 - S9.
46. WONG, W-S F., BLOOMQUIST, S.L., BENDELE, A.M. & FLEISCH, J.H. (1992). Pharmacological and histological examinations of regional differences of guinea-pig lung: a role of pleural surface smooth muscle in lung strip contraction. Br. J. Pharmacol., 105, 620 - 626.
47. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411 - 415.